Efficacy and safety of elobixibat in psychiatric disorders patients with chronic constipation -Retrospective observation research
- Conditions
- Psychiatric disorders patients with chronic constipation
- Registration Number
- JPRN-UMIN000042139
- Lead Sponsor
- agisa clinic
- Brief Summary
This study was a retrospective study on effectiveness and safety of elobixibat for chronic constipation in 28 psychiatric outpatients such as depression and schizophrenia. There was a significant increase in frequency of bowel movements per week, 4 and 52 weeks after treatment with elobixibat compared to that before the treatment. In addition, adverse events were observed in 3 patients, although those were not serious including mild diarrhea. (The Japanese Journal of Psychiatry. 2021; 26(6): 553-560)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 28
Not provided
1. Patients with a history of hypersensitivity to elobixibat 2. Patients with confirmed or suspected bowel obstruction due to a tumor or hernia 3. Patients with suspected constipation due to organic disease 4. Patients diagnosed with dementia 5. Patients who have been determined by a physician to be inappropriate to administrate elobixibat
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method